Mejdoubi Mehdi, Gigaud Michel, Trémoulet Michel, Albucher Jean-François, Cognard Christophe
Department of Neuroradiology, Hôpital Purpan, University of Toulouse, Toulouse, France.
Neuroradiology. 2006 Dec;48(12):899-905. doi: 10.1007/s00234-006-0144-6. Epub 2006 Sep 27.
From January 1998 to December 2002, endovascular treatment (EVT) was used as first intention in all patients with ruptured aneurysms. The objective of this study was to analyze the results of this therapeutic strategy.
Among 401 patients admitted with a subarachnoid hemorrhage (SAH), 73 (18%) had a nonaneurysmal perimesencephalic SAH, 28 were not explored by angiography due to very poor clinical status, and 28 with aneurysmal SAH were not treated due to poor clinical status. Thus, of the 300 patients with a proven aneurysmal SAH, 272 (83%) were treated. EVT was attempted in 230 patients and was successful in 222 (82%), and clipping was performed in 50 (18%).
Finally, EVT was successful in 234 aneurysms (96.7%) in 222 patients out of 242 aneurysms in 230 patients (some of the patients were treated for more than one aneurysm in the same procedure). EVT-related morbidity occurred in ten patients (4.5%) and mortality in eight (3.6%). Rate of dependency or death (modified Rankin scale 3-5) was 24.5% at 26 months. Initially, complete aneurysm occlusion was obtained in 81%, a dog ear in 3.4%, a neck remnant in 8% and incomplete occlusion in 8.1% of the patients. At follow-up (mean 26 months), the occlusion rate remained stable at 75%.
This consecutive prospective series shows that EVT can be performed routinely as first-intention treatment in most aneurysmal SAH. Using this therapeutic strategy, EVT was performed in 82% of patients with long-term clinical results similar to those of the ISAT study.
1998年1月至2002年12月,血管内治疗(EVT)被用作所有破裂动脉瘤患者的首选治疗方法。本研究的目的是分析这一治疗策略的结果。
在401例蛛网膜下腔出血(SAH)患者中,73例(18%)为非动脉瘤性中脑周围SAH,28例因临床状况极差未行血管造影检查,28例动脉瘤性SAH患者因临床状况差未接受治疗。因此,在300例经证实为动脉瘤性SAH的患者中,272例(83%)接受了治疗。230例患者尝试了EVT,222例(82%)成功,50例(18%)进行了夹闭术。
最终,在230例患者的242个动脉瘤中,222例患者的234个动脉瘤(96.7%)EVT治疗成功(部分患者在同一次手术中治疗了不止一个动脉瘤)。10例患者(4.5%)发生了与EVT相关的并发症,8例患者(3.6%)死亡。在26个月时,依赖或死亡发生率(改良Rankin量表3 - 5级)为24.5%。最初,81%的患者实现了动脉瘤完全闭塞,3.4%有“狗耳”残留,8%有颈部残留,8.1%为不完全闭塞。随访(平均26个月)时,闭塞率稳定在75%。
这个连续的前瞻性系列研究表明,EVT可作为大多数动脉瘤性SAH的首选常规治疗方法。采用这一治疗策略,82%的患者接受了EVT治疗,长期临床结果与国际蛛网膜下腔出血动脉瘤试验(ISAT)研究相似。